ID
12574
Beschrijving
Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01804101
Link
https://clinicaltrials.gov/show/NCT01804101
Trefwoorden
Versies (1)
- 02-12-15 02-12-15 -
Geüploaded op
2 december 2015
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Acute Biphenotypic Leukemia NCT01804101
Eligibility Acute Biphenotypic Leukemia NCT01804101
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
refractory/relapsing blast crisis of chronic myelogenous leukemia (cml)
Datatype
boolean
Alias
- UMLS CUI [1]
- C2861579
- UMLS CUI [2]
- C0205269
Beschrijving
Comorbidity with a likely survival of < 1 year
Datatype
boolean
Alias
- UMLS CUI [1]
- C0009488
- UMLS CUI [2]
- C2919552
Beschrijving
infection, unless under treatment
Datatype
boolean
Alias
- UMLS CUI [1]
- C0009450
- UMLS CUI [2]
- C0087111
Similar models
Eligibility Acute Biphenotypic Leukemia NCT01804101
- StudyEvent: Eligibility
C0026998 (UMLS CUI [2])
C0521104 (UMLS CUI [2])
C1706472 (UMLS CUI [3])
C0023416 (UMLS CUI [2])
C0205269 (UMLS CUI [2])
C2919552 (UMLS CUI [2])
C0087111 (UMLS CUI [2])